Report cover image

Global miRNA Market 2023-2027

Publisher TechNavio
Published Aug 23, 2023
Length 159 Pages
SKU # INF18180559

Description

Global MiRNA Market 2023-2027


The MiRNA market is forecasted to grow by USD 2,020.12 mn during 2022-2027, accelerating at a CAGR of 18.91% during the forecast period. The report on the MiRNA market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of neurological disorders, significant scientific progress in MiRNA approach, and high heterogeneity of methodologies associated with MiRNA.

Technavio's MiRNA market is segmented as below:

By Type
  • Consumables
  • Instruments
By End-user
  • Academic and government research institutes
  • Biotechnology and pharmaceutical companies
  • CROs and clinical diagnostic centers
By Geography
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing number of partnerships and collaborations of market vendors as one of the prime reasons driving the MiRNA market growth during the next few years. Also, rapid growth potential in developing economies and growing adoption of artificial intelligence for disease evaluation will lead to sizable demand in the market.

The report on the MiRNA market covers the following areas:
  • MiRNA market sizing
  • MiRNA market forecast
  • MiRNA market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading MiRNA market vendors that include BioGenex Laboratories Inc., BioVendor Laboratorni medicina AS, GeneCopoeia Inc., Genelinx International Inc., HEIM BIOTEK, Illumina Inc., InteRNA Technologies B.V., Merck KGaA, NanoString Technologies Inc., New England Biolabs Inc., OriGene Technologies Inc., PerkinElmer Inc., QIAGEN NV, Quantabio, Regulus Therapeutics Inc., SeqMatic LLC, Takara Bio Inc., TAMiRNA GmbH, Thermo Fisher Scientific Inc., and Miltenyi Biotec B.V. and Co. KG. Also, the MiRNA market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

159 Pages
    • Market overview
    • Market ecosystem
    • Market definition
    • Market segment analysis
    • Market size 2022
    • Market outlook: Forecast for 2022-2027
    • Global miRNA market 2017 - 2021
    • Type Segment Analysis 2017 - 2021
    • End-user Segment Analysis 2017 - 2021
    • Geography Segment Analysis 2017 - 2021
    • Country Segment Analysis 2017 - 2021
    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
    • Market segments
    • Comparison by Type
    • Consumables - Market size and forecast 2022-2027
    • Instruments - Market size and forecast 2022-2027
    • Market opportunity by Type
    • Market segments
    • Comparison by End-user
    • Academic and government research institutes – Market size and forecast 2022-2027
    • Biotechnology and pharmaceutical companies – Market size and forecast 2022-2027
    • CROs and clinical diagnostic centers - Market size and forecast 2022-2027
    • Market opportunity by End-user
    • Customer landscape overview
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2022-2027
    • Europe - Market size and forecast 2022-2027
    • Asia - Market size and forecast 2022-2027
    • Rest of World (ROW) - Market size and forecast 2022-2027
    • US - Market size and forecast 2022-2027
    • Germany - Market size and forecast 2022-2027
    • UK - Market size and forecast 2022-2027
    • Canada - Market size and forecast 2022-2027
    • China - Market size and forecast 2022-2027
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Impact of drivers and challenges
    • Market trends
    • Overview
    • Vendor landscape
    • Landscape disruption
    • Industry risks
    • Vendors covered
    • Market positioning of vendors
    • BioVendor Laboratorni medicina AS
    • GeneCopoeia Inc.
    • HEIM BIOTEK
    • Illumina Inc.
    • Merck KGaA
    • Miltenyi Biotec B.V. and Co. KG
    • NanoString Technologies Inc.
    • New England Biolabs Inc.
    • OriGene Technologies Inc.
    • PerkinElmer Inc.
    • QIAGEN NV
    • Quantabio
    • Regulus Therapeutics Inc.
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
    • Scope of the report
    • Inclusions and exclusions checklist
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us